Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FETX1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $161,702
Award facts
- Contract value 100% obligated
- $161,702.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of STELARA 45 mg/0.5 mL syringes with a ceiling value of $161,702.05. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitive federal contract awards with the Defense Logistics Agency. The company's federal contracting demonstrates significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for STELARA, a specialty pharmaceutical product, reflects AmerisourceBergen's role in supporting Defense Health Agency and military healthcare system needs as part of the DLA's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FETX1?
SPE2DB25FETX1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FETX1 worth?
The government has obligated $161,702 on SPE2DB25FETX1.
Is contract SPE2DB25FETX1 an order under another contract?
Yes. SPE2DB25FETX1 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FETX1 competed?
The extent of competition for SPE2DB25FETX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award